UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib

Clinical pharmacokinetics, 2016-10, Vol.55 (10), p.1191-1204

2016

Volltextzugriff (PDF)

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer

British journal of cancer, 2018-08, Vol.119 (3), p.266-273

2018

Volltextzugriff (PDF)

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Journal of clinical oncology, 2010-03, Vol.28 (8), p.1301-1307

2010

Volltextzugriff (PDF)

Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2–Dependent and Other Solid Tumors

Journal of clinical oncology, 2014-01, Vol.32 (2), p.68-75

2014

Volltextzugriff (PDF)

Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions

Drug metabolism and disposition, 2017-04, Vol.45 (4), p.390-398

2017

Volltextzugriff (PDF)

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

Clinical cancer research, 2009-04, Vol.15 (7), p.2552-2558

2009

Volltextzugriff (PDF)

A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects

International journal of cancer, 2012-08, Vol.131 (3), p.E304-E311

2012

Volltextzugriff (PDF)

Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole

Clinical therapeutics, 2018-05, Vol.40 (5), p.733-740

2018

Volltextzugriff (PDF)

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects

Cancer chemotherapy and pharmacology, 2012-01, Vol.69 (1), p.221-227

2012

Volltextzugriff (PDF)

Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease

PloS one, 2015-06, Vol.10 (6), p.e0128986

2015

Volltextzugriff (PDF)

Population Pharmacokinetic and Pharmacodynamic Analysis of Bosutinib

DRUG METABOLISM AND PHARMACOKINETICS, 2014, Vol.29 (6), p.441-448

2014

Volltextzugriff (PDF)

Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects

Clinical pharmacology in drug development, 2022-01, Vol.11 (1), p.100-111

2022

Volltextzugriff (PDF)

Effect of Ketoconazole on the Pharmacokinetics of Oral Bosutinib in Healthy Subjects

Journal of clinical pharmacology, 2011-12, Vol.51 (12), p.1721-1727

2011

Volltextzugriff (PDF)

Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations

Clinical pharmacology in drug development, 2018-05, Vol.7 (4), p.441-450

2018

Volltextzugriff (PDF)

Retraction notice to “Population pharmacokinetic and pharmacodynamic analysis of bosutinib” [Drug Metab Pharmacokinet 29 (2014) 441–448]

Drug metabolism and pharmacokinetics, 2019-04, Vol.34 (2), p.163-163

2019

Volltextzugriff (PDF)

A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects

Clinical pharmacology in drug development, 2020-04, Vol.9 (3), p.307-320

2020

Volltextzugriff (PDF)

Single-Dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-Release Chewable Tablet Compared With Immediate-Release Methylphenidate Chewable Tablet

Clinical therapeutics, 2016-05, Vol.38 (5), p.1151-1157

2016

Volltextzugriff (PDF)

4.7 EFFICACY OF METHYLPHENIDATE EXTENDED-RELEASE CHEWABLE TABLETS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: OPEN-LABEL, DOSE-OPTIMIZATION PERIOD OUTCOMES

Journal of the American Academy of Child and Adolescent Psychiatry, 2016-10, Vol.55 (10), p.S164-S165

2016

Volltextzugriff (PDF)

Ascending Single-Dose Study of the Safety Profile, Tolerability, and Pharmacokinetics of Bosutinib Coadministered With Ketoconazole to Healthy Adult Subjects

Clinical therapeutics, 2012-09, Vol.34 (9), p.2011-2019.e1

2012

Volltextzugriff (PDF)

A Phase I Study of EKB-569 in Combination with Capecitabine in Patients with Advanced Colorectal Cancer

Clinical cancer research, 2008-09, Vol.14 (17), p.5602-5609

2008

Volltextzugriff (PDF)

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Blood, 2011-10, Vol.118 (17), p.4567-4576

2011

Volltextzugriff (PDF)

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder

Journal of child and adolescent psychopharmacology, 2020-03, Vol.30 (2), p.104-118

2020

Volltextzugriff (PDF)

Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects

Drug metabolism and personalized therapy, 2015-03, Vol.30 (1), p.57-63

2015

Volltextzugriff (PDF)

Considerations in the early development of biosimilar products

Drug discovery today, 2015-05, Vol.20, p.1-9

2015

Volltextzugriff (PDF)

1 – 25 von 55

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(53)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(54)
Dissertationen
(1)

Sprache

Englisch
(55)

Erscheinungsjahr

n.n

Thema

Science & Technology
(42)
Life Sciences & Biomedicine
(41)
Humans
(32)
Male
(27)
Pharmacology & Pharmacy
(26)
Adult
(25)
Female
(23)
Middle Aged
(22)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Area Under Curve
(16)
Young Adult
(16)
Oncology
(15)
Quinolines - Pharmacokinetics
(15)
Pharmacokinetics
(14)
Quinolines - Adverse Effects
(14)
Quinolines - Administration & Dosage
(13)
Pharmacology. Drug Treatments
(12)
Administration, Oral
(11)
Adolescent
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Clinical Pharmacokinetics and Pharmacodynamics of Bosutinib

Neoadjuvant PF-05280014 (a potential trastuzumab biosimilar) versus trastuzumab for operable HER2+ breast cancer

Neratinib, an Irreversible ErbB Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced ErbB2-Positive Breast Cancer

Phase I Study of Neratinib in Combination With Temsirolimus in Patients With Human Epidermal Growth Factor Receptor 2–Dependent and Other Solid Tumors

Application of Physiologically Based Pharmacokinetic Modeling to the Understanding of Bosutinib Pharmacokinetics: Prediction of Drug-Drug and Drug-Disease Interactions

A Phase I Study with Neratinib (HKI-272), an Irreversible Pan ErbB Receptor Tyrosine Kinase Inhibitor, in Patients with Solid Tumors

A randomized, crossover, placebo- and moxifloxacin-controlled study to evaluate the effects of bosutinib (SKI-606), a dual Src/Abl tyrosine kinase inhibitor, on cardiac repolarization in healthy adult subjects

Relative Bioavailability of Methylphenidate Extended-release Chewable Tablets Chewed Versus Swallowed Whole

A phase I ascending single-dose study of the safety, tolerability, and pharmacokinetics of bosutinib (SKI-606) in healthy adult subjects

Pharmacokinetics of Novel Plant Cell-Expressed Taliglucerase Alfa in Adult and Pediatric Patients with Gaucher Disease

Population Pharmacokinetic and Pharmacodynamic Analysis of Bosutinib

Lack of an Effect of Supratherapeutic Dose of Venlafaxine on Cardiac Repolarization in Healthy Subjects

Effect of Ketoconazole on the Pharmacokinetics of Oral Bosutinib in Healthy Subjects

Population Pharmacokinetics of Desvenlafaxine: Pharmacokinetics in Korean Versus US Populations

Retraction notice to “Population pharmacokinetic and pharmacodynamic analysis of bosutinib” [Drug Metab Pharmacokinet 29 (2014) 441–448]

A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects

Single-Dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-Release Chewable Tablet Compared With Immediate-Release Methylphenidate Chewable Tablet

4.7 EFFICACY OF METHYLPHENIDATE EXTENDED-RELEASE CHEWABLE TABLETS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER: OPEN-LABEL, DOSE-OPTIMIZATION PERIOD OUTCOMES

Ascending Single-Dose Study of the Safety Profile, Tolerability, and Pharmacokinetics of Bosutinib Coadministered With Ketoconazole to Healthy Adult Subjects

A Phase I Study of EKB-569 in Combination with Capecitabine in Patients with Advanced Colorectal Cancer

Phase I Pharmacokinetic/Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer

Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder

Effect of rifampin on the pharmacokinetics of bosutinib, a dual Src/Abl tyrosine kinase inhibitor, when administered concomitantly to healthy subjects

Considerations in the early development of biosimilar products

Suchergebnisse filtern